Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study.
Carubbi F, Cipriani P, Marrelli A, Benedetto P, Ruscitti P, Berardicurti O, Pantano I, Liakouli V, Alvaro S, Alunno A, Manzo A, Ciccia F, Gerli R, Triolo G, Giacomelli R. Carubbi F, et al. Among authors: alvaro s. Arthritis Res Ther. 2013 Oct 30;15(5):R172. doi: 10.1186/ar4359. Arthritis Res Ther. 2013. PMID: 24286296 Free PMC article.
Increased Cardiovascular Events and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients: 1 Year Prospective Single Centre Study.
Ruscitti P, Cipriani P, Masedu F, Romano S, Berardicurti O, Liakouli V, Carubbi F, Di Benedetto P, Alvaro S, Penco M, Valenti M, Giacomelli R. Ruscitti P, et al. Among authors: alvaro s. PLoS One. 2017 Jan 19;12(1):e0170108. doi: 10.1371/journal.pone.0170108. eCollection 2017. PLoS One. 2017. PMID: 28103312 Free PMC article.
Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial.
Ruscitti P, Masedu F, Alvaro S, Airò P, Battafarano N, Cantarini L, Cantatore FP, Carlino G, D'Abrosca V, Frassi M, Frediani B, Iacono D, Liakouli V, Maggio R, Mulè R, Pantano I, Prevete I, Sinigaglia L, Valenti M, Viapiana O, Cipriani P, Giacomelli R. Ruscitti P, et al. Among authors: alvaro s. PLoS Med. 2019 Sep 12;16(9):e1002901. doi: 10.1371/journal.pmed.1002901. eCollection 2019 Sep. PLoS Med. 2019. PMID: 31513665 Free PMC article. Clinical Trial.
Angiogenic cytokines and growth factors in systemic sclerosis.
Liakouli V, Cipriani P, Marrelli A, Alvaro S, Ruscitti P, Giacomelli R. Liakouli V, et al. Among authors: alvaro s. Autoimmun Rev. 2011 Aug;10(10):590-4. doi: 10.1016/j.autrev.2011.04.019. Epub 2011 Apr 28. Autoimmun Rev. 2011. PMID: 21549861 Review.
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients.
Ruscitti P, Cipriani P, Di Benedetto P, Liakouli V, Berardicurti O, Carubbi F, Ciccia F, Alvaro S, Triolo G, Giacomelli R. Ruscitti P, et al. Among authors: alvaro s. Clin Exp Immunol. 2015 Oct;182(1):35-44. doi: 10.1111/cei.12667. Epub 2015 Jul 19. Clin Exp Immunol. 2015. PMID: 26095630 Free PMC article.
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study.
Ruscitti P, Ursini F, Cipriani P, Greco M, Alvaro S, Vasiliki L, Di Benedetto P, Carubbi F, Berardicurti O, Gulletta E, De Sarro G, Giacomelli R. Ruscitti P, et al. Among authors: alvaro s. Medicine (Baltimore). 2019 Feb;98(7):e14587. doi: 10.1097/MD.0000000000014587. Medicine (Baltimore). 2019. PMID: 30762811 Free PMC article.
17 results